With two observations
Granules India announced that USFDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 25 June 2021 with two (2) minor observations. This is a pre-approval inspection for the products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
